Table 2

Gene signatures of plasma-cell differentiation in bortezomib-adapted MCL cell lines

Gene signatureHBL2 BR
JEKO BR
NESFDRNESFDR
IRF4 high plasma cell vs B cell* 1.44 0.04 1.91 < 0.001 
Plasma cell vs B cell* 1.52 0.08 1.65 0.03 
Plasmablast high plasma cell low* 1.54 0.10 ns ns 
Plasma cell high plasmablast low* ns ns 1.69 0.03 
BLIMP B cell repressed* −2.48 < 0.001 ns ns 
Early differentiation genes −1.47 0.07 ns ns 
Gene signatureHBL2 BR
JEKO BR
NESFDRNESFDR
IRF4 high plasma cell vs B cell* 1.44 0.04 1.91 < 0.001 
Plasma cell vs B cell* 1.52 0.08 1.65 0.03 
Plasmablast high plasma cell low* 1.54 0.10 ns ns 
Plasma cell high plasmablast low* ns ns 1.69 0.03 
BLIMP B cell repressed* −2.48 < 0.001 ns ns 
Early differentiation genes −1.47 0.07 ns ns 

GSEA was used to test for significant enrichment of defined plasma-cell differentiation signatures. NES indicates normalized enriched score; FDR, false discovery rate; and ns, not significant (FDR > 0.10).

*

Gene signatures of plasma cell differentiation were downloaded from http://lymphochip.nih.gov/signaturedb/index.html.34 

Gene signatures of plasma cell differentiation were extracted from the data of Zhan et al.35 

Close Modal

or Create an Account

Close Modal
Close Modal